The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A multinational phase III randomized trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent chemoradiation in inoperable stage III non-small cell lung cancer (CCheIN).
Keunchil Park
No relevant relationships to disclose
Yong Chan Ahn
No relevant relationships to disclose
Jin Seok Ahn
No relevant relationships to disclose
Myung-Ju Ahn
No relevant relationships to disclose
Joo-Hang Kim
No relevant relationships to disclose
Eun Kyung Cho
No relevant relationships to disclose
Kyu Chan Lee
No relevant relationships to disclose
Chang Geol Lee
No relevant relationships to disclose
Ming Chen
No relevant relationships to disclose
Dae Seog Heo
No relevant relationships to disclose
Hoon-Kyo Kim
No relevant relationships to disclose
Young Joo Min
No relevant relationships to disclose
Jin Hyoung Kang
No relevant relationships to disclose
Jin-Hyuk Choi
No relevant relationships to disclose
Sang-We Kim
No relevant relationships to disclose
Guangying Zhu
No relevant relationships to disclose
Yi-Long Wu
No relevant relationships to disclose
Sung Rok Kim
No relevant relationships to disclose
Kyung Hee Lee
No relevant relationships to disclose
Hong-Suk Song
No relevant relationships to disclose